Cargando…
The expression of hypoxia inducible factor-1 alpha in diffuse large B-cell lymphoma (DLBCL) patients: a cross-sectional study in Indonesia
INTRODUCTION: Hypoxia fuels cancer growth by supporting blood vessel formation, suppressing immune response, and helping cancer cells adapt to harsh surroundings. This happens when cancer cells react to low oxygen levels by activating hypoxia inducible factor-1 alpha (HIF-1α). High levels of HIF-1α...
Autores principales: | Pangarsa, Eko Adhi, Rizky, Daniel, Tandarto, Kevin, Naibaho, Ridho M., Kurniawan, Sigit P., Istiadi, Hermawan, Puspasari, Dik, Santoso, Antonius Gunawan, Setiawan, Budi, Santosa, Damai, Haryana, Sofia Mubarika, Suharti, Catharina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553143/ https://www.ncbi.nlm.nih.gov/pubmed/37811023 http://dx.doi.org/10.1097/MS9.0000000000001162 |
Ejemplares similares
-
Preliminary study of hypoxia markers in diffuse large B-cell lymphoma
por: Pangarsa, Eko A., et al.
Publicado: (2022) -
Establishing the hematopoietic stem cell transplant (HSCT) in a developing country; the journey of HSCT in Semarang, Indonesia
por: Santosa, Damai, et al.
Publicado: (2020) -
The Use of Etoposide, Ara-Cytarabine, and Melphalan (EAM) Conditioning Chemotherapy in Autologous Stem Cell Transplantation (ASCT) for a Patient with Relapsed Hodgkin's Lymphoma
por: Pangarsa, Eko A., et al.
Publicado: (2021) -
Von Willebrand factor:antigen and ADAMTS-13 level, but not soluble P-selectin, are risk factors for the first asymptomatic deep vein thrombosis in cancer patients undergoing chemotherapy
por: Setiawan, Budi, et al.
Publicado: (2020) -
Clinical Evaluation for the Role of High-Sensitivity C-Reactive Protein in Combination with D-Dimer and Wells Score Probability Test to Predict the Incidence of Deep Vein Thrombosis Among Cancer Patients
por: Setiawan, Budi, et al.
Publicado: (2020)